您当前的位置：
首页 >
文章列表页 >
Network Meta-analysis of Oral Chinese Patent Medicine in Adjuvant Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
更新时间：2024-04-16
|

    • Network Meta-analysis of Oral Chinese Patent Medicine in Adjuvant Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 9, Pages: 174-185(2024)

    • DOI：10.13422/j.cnki.syfjx.20230812    

      CLC： R284;R285;R289;R287;R22;R2-031;R33;R24

    • Published：05 May 2024，

      Published Online：26 June 2023，

      Received：21 March 2023，

    扫 描 看 全 文

  • YU Binyang,YANG Jing,DAI Xinyue,et al.Network Meta-analysis of Oral Chinese Patent Medicine in Adjuvant Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(09):174-185. DOI： 10.13422/j.cnki.syfjx.20230812.

  •  
  •  

0

Views

25

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

GRADE Clinical Study Evidence Evaluation and Expert Consensus on Antihypertensive Chinese Patent Medicines Combined with Western Medicines for Treatment of Hypertension
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Clinical Evidence Mapping of Chinese Patent Medicines Combined with Western Medicine in Treatment of Hypertension
Construction and Interpretation of Clinical Comprehensive Evaluation Index System for Chinese Patent Medicine Based on EVIDEM Framework

Related Author

CUI Liangyu
LI Yukun
JING Tianyue
WANG Yu
REN Cong
YIN Tong
ZHAO Zhiwei
WANG Jiaheng

Related Institution

Air Force Military Medical University
Shaanxi University of Chinese Medicine
Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences
Dongzhimen Hospital，Beijing University of Chinese Medicine
The research center of national drug policy & ecosystem，China pharmaceutical university
0